3 best performing ASX shares in the week of 10 October 2022

Marc Kennis Marc Kennis, October 17, 2022

The 3 best performing ASX shares in the week of 3 October 2022

The 3 best performing ASX shares of the week starting 10 October 2022 were Cettire (ASX:CTT), up 46.4%, Nova Eye Medical (ASX:EYE), up 42.5%, and Element 25 (ASX:E25), up 34.2%.

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Cettire (ASX:CTT)

Industry: Consumer Discretionary

Cettire Limited (ASX:CTT) is a global online retailer, offering a selection of in-demand personal luxury goods via its website, cettire.com. Cettire has access to a catalogue of over 1,700 luxury brands and over 190,000 products of clothing, shoes, bags and accessories.

Market Cap: $505m

12 month high / low: $0.33 – $4.81

 

Cettire

 

 

2. Nova Eye Medical (ASX:EYE)

Industry: Healthcare

Nova Eye Medical Limited (ASX:EYE, formerly Ellex Medical Lasers Limited) is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices.

Market Cap: $42m

12 month high / low: $0.18 – $0.42

 

Nova Eye Medical

 

 

3. Element 25 (ASX:E25)

Industry: Resources

Element 25 Limited (ASX:E25, formerly Montezuma Mining Company Ltd) rounds out the top 3 best performing ASX shares this week. E25 is a mineral exploration and mining company exploring for manganese, copper and gold deposits in Western Australia. The Company has a 100% interest in Yamarna Gold Project, Butcherbird Manganese-Copper Project and Green Dam Project.

Market Cap: $159m

12 month high / low: $0.425 – $2.05

 

Energy 25

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Nuix

Nuix (ASX:NXL) has quadrupled in 12 months! But is more growth to come?

Nuix (ASX:NXL) has been one of the most controversial companies on the ASX since it listed, but has it turned…

ASX Biotechs

Here are 3 ASX biotechs with major milestones coming right up!

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

buy the dip

When do you know it’s time to ‘buy the dip’? You could be catching a falling knife

‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases,…